These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 30747704)
41. Recombinant lys-plasminogen given before, but not after, recombinant tissue-type plasminogen activator markedly improves coronary thrombolysis in dogs: relationship of thrombolytic efficacy with parameters of fibrinolysis. Chen LY; Nichols WW; Saldeen TG; Mehta JL J Cardiovasc Pharmacol; 1996 Feb; 27(2):283-9. PubMed ID: 8720429 [TBL] [Abstract][Full Text] [Related]
42. [Correlations between ROTEM fibrinolytic activity and t-PA, PAI-1 levels in patients with newly diagnosed multiple myeloma]. Misiewicz M; Robak M; Chojnowski K; Treliński J Pol Merkur Lekarski; 2014 May; 36(215):316-9. PubMed ID: 24964508 [TBL] [Abstract][Full Text] [Related]
43. External pneumatic compression and fibrinolysis in abdominal surgery. Cahan MA; Hanna DJ; Wiley LA; Cox DK; Killewich LA J Vasc Surg; 2000 Sep; 32(3):537-43. PubMed ID: 10957661 [TBL] [Abstract][Full Text] [Related]
44. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects. Stegnar M; Mavri A Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828 [TBL] [Abstract][Full Text] [Related]
45. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome. Mehta P; Parker RI J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427 [TBL] [Abstract][Full Text] [Related]
46. Fibrinolytic activity in laparoscopic cholecystectomy. Martinez-Ramos C; Lopez-Pastor A; Núñez-Peña JR; Ruiz-Caravaca ML; Ruiz de Gopegui M; Sanz-López R; Jorgensen TW; Tamames-Escobar S J Laparoendosc Adv Surg Tech A; 1998 Dec; 8(6):417-23. PubMed ID: 9916595 [TBL] [Abstract][Full Text] [Related]
47. Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism. Ermantas N; Guldiken S; Demir M; Tugrul A Clin Appl Thromb Hemost; 2010 Oct; 16(5):568-73. PubMed ID: 19959491 [TBL] [Abstract][Full Text] [Related]
48. Tissue plasminogen activator and plasminogen activator inhibitor status in Budd-Chiari syndrome. Dayal S; Pati HP; Sharma MP Haemostasis; 1996; 26(5):284-7. PubMed ID: 8894659 [TBL] [Abstract][Full Text] [Related]
49. [Changes in plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) by the interferon treatment for chronic hepatitis C]. Hayashi T; Ro S; Kamogawa A; Kobayashi Y; Suzuki Y; Imai M; Okuse C; Ozaki M; Iwabuchi S; Murayama M Rinsho Byori; 1995 Sep; 43(9):948-52. PubMed ID: 7474459 [TBL] [Abstract][Full Text] [Related]
50. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor. Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039 [TBL] [Abstract][Full Text] [Related]
51. Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. Kaspar M; Ramsay MA; Nguyen AT; Cogswell M; Hurst G; Ramsay KJ Anesth Analg; 1997 Aug; 85(2):281-5. PubMed ID: 9249100 [TBL] [Abstract][Full Text] [Related]
52. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity]. Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860 [TBL] [Abstract][Full Text] [Related]
53. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma. Sørensen JV Blood Coagul Fibrinolysis; 1994 Feb; 5(1):43-9. PubMed ID: 7514044 [TBL] [Abstract][Full Text] [Related]
54. Alterations in the fibrinolytic system components during acute myocardial infarction. Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123 [TBL] [Abstract][Full Text] [Related]
55. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. Teng YC; Lin QD; Lin JH; Ding CW; Zuo Y J Perinat Med; 2009; 37(4):343-8. PubMed ID: 19290852 [TBL] [Abstract][Full Text] [Related]
56. Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity. Kopeikina LT; Kamper EF; Koutsoukos V; Bassiakos Y; Stavridis I Clin Rheumatol; 1997 May; 16(3):254-60. PubMed ID: 9184262 [TBL] [Abstract][Full Text] [Related]
57. Fibrinolysis resistance after liver transplant as a predictor of early infection. Rodriguez IE; Yoeli D; Ferrell T; Jiang JG; Truong R; Nydam TL; Adams MA; Cullen JM; Pomfret EA; Moore HB Am J Surg; 2022 Dec; 224(6):1455-1459. PubMed ID: 36153270 [TBL] [Abstract][Full Text] [Related]
58. The effect of chronic allograft rejection on plasma regulators of fibrinolysis. Perkowska A; Elhasade A; Durlik M; Placha G; Gałazka Z; Lao M; Gaciong Z Ann Transplant; 2002; 7(1):44-51. PubMed ID: 12221903 [TBL] [Abstract][Full Text] [Related]
60. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery. Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]